CS logo
small CS logo
CITrials

Bellflower, California, United States
Research institute in Bellflower, California
17800 Woodruff Ave ste b, Bellflower, CA 90706

About CITrials


"For over two decades, CIT has been dedicated to assisting pharmaceutical companies find new cures to help patients better manage their healthcare."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Otsuka Pharmaceutical Development & Commercialization, Inc.
4
Hoffmann-La Roche
3
Forest Laboratories
2
Karuna Therapeutics
2
Takeda
2
AbbVie
1
Allergan
1
Assurex Health Inc.
1
BlackThorn Therapeutics, Inc.
1
Boehringer Ingelheim
1
Cerecin
1
Total Rows: 17

Clinical Trials at CITrials


During the past decade, CITrials conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 9 clinical trials were completed, i.e. on average, 45% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 6 clinical trials were completed. i.e. 100% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years4400223355333300001100224411Started TrialsCompleted Trails20152016201720182019202020210246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
2012-10-01
2016-05-01
Completed
800
AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext
2013-03-01
2017-04-14
Completed
418
Adaptive Phase II Study to Evaluate the Safety & Efficacy of NaBen®
2014-06-01
2023-12-31
Recruiting
126
Genomics Used to Improve DEpression Decisions
2014-04-01
2017-07-31
Completed
1,398
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
2014-04-22
2016-12-22
Completed
258
Safety and Efficacy of Vilazodone in Pediatric Patients With Major Depressive Disorder (VLZ-MD-22)
2015-02-28
2018-09-11
Completed
473
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
2015-05-02
2018-07-23
Completed
330
Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee
2015-07-21
2019-02-27
Completed
3,021

Rows per page:

1–25 of 25

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "CITrials" #1 sponsor was "Otsuka Pharmaceutical Development & Commercialization, Inc." with 4 trials, followed by "Hoffmann-La Roche" with 3 trials sponsored, "Forest Laboratories" with 2 trials sponsored, "Karuna Therapeutics" with 2 trials sponsored and "Takeda" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "CITrials" #1 collaborator was "H. Lundbeck A/S" with 2 trials as a collaborator, "Neumora Therapeutics, Inc." with 1 trials as a collaborator, "PRA Health Sciences" with 1 trials as a collaborator and "University of Michigan" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.
Created with Highcharts 11.1.0Top Leading SponsorsOtsuka PharmaceuticalDevelopment &Commercialization, Inc.:4Otsuka PharmaceuticalDevelopment &Commercialization, Inc.:4Hoffmann-La Roche: 3Hoffmann-La Roche: 3Forest Laboratories: 2Forest Laboratories: 2Karuna Therapeutics: 2Karuna Therapeutics: 2Takeda: 2Takeda: 2AbbVie: 1AbbVie: 1Allergan: 1Allergan: 1Assurex Health Inc.: 1Assurex Health Inc.: 1BlackThorn Therapeutics, Inc.: 1BlackThorn Therapeutics, Inc.: 1Boehringer Ingelheim: 1Boehringer Ingelheim: 1

Created with Highcharts 11.1.0Top CollaboratorsH. Lundbeck A/S: 2H. Lundbeck A/S: 2Neumora Therapeutics, Inc.: 1Neumora Therapeutics, Inc.: 1PRA Health Sciences: 1PRA Health Sciences: 1University of Michigan: 1University of Michigan: 1

Clinical Trials Conditions at CITrials


According to Clinical.Site data, the most researched conditions in "CITrials" are "Schizophrenia" (8 trials), "Alzheimer's Disease" (4 trials), "Bipolar I Disorder" (3 trials), "Major Depressive Disorder" (3 trials) and "Schizophrenia, Schizoaffective Disorder" (2 trials). Many other conditions were trialed in "CITrials" in a lesser frequency.

Clinical Trials Intervention Types at CITrials


Most popular intervention types in "CITrials" are "Drug" (23 trials), "Biological" (2 trials), "Combination Product" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (17 trials), "Brexpiprazole" (2 trials), "RO6889450" (2 trials), "TAK-994" (2 trials) and "Vilazodone" (2 trials). Other intervention names were less common.

Clinical Trials Genders at CITrials


The vast majority of trials in "CITrials" are 24 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at CITrials


Currently, there are NaN active trials in "CITrials". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in CITrials, undefined suspended trials, and 6 terminated clinical trials to date.
Out of the total trials that were conducted in CITrials, 1 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 15Phase 3: 15Phase 2: 11Phase 2: 11Not Applicable: 1Not Applicable: 1Phase 1: 1Phase 1: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 13Completed: 13Terminated: 6Terminated: 6Recruiting: 3Recruiting: 3Active, not recruiting: 2Active, not recruiting: 2Unknown status: 1Unknown status: 1